Tofacitinib in Stricturing Colonic Crohn's Disease

Tofacitinib has described efficacy in ulcerative colitis but not Crohn's disease (CD). However, patients with stricturing CD were excluded from initial randomized controlled trials. We report a case of stricturing colonic CD, which responded to tofacitinib therapy.

Authors

Institutions

Publication Details

Journal
ACG Case Reports Journal
Published
2025-05-01
DOI
https://doi.org/10.14309/crj.0000000000001692
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tofacitinib in Stricturing Colonic Crohn's Disease

Matthew C. Choy, Peter De Cruz, Simone Chin
1 links
ACG Case Reports Journal
Inflammatory Bowel Disease
article

Tofacitinib in Stricturing Colonic Crohn's Disease

Matthew C. Choy, Peter De Cruz, Simone Chin
article en

Abstract

Tofacitinib has described efficacy in ulcerative colitis but not Crohn's disease (CD). However, patients with stricturing CD were excluded from initial randomized controlled trials. We report a case of stricturing colonic CD, which responded to tofacitinib therapy.

ACG Case Reports JournalVol. 12(5)
The University of Melbourne (AU), Austin Health (AU)
Good health and well-being
Openalex Percentile: Top 89%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.